Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0000950170-24-125822

Chief Financial Officer sold 800 shares at $70.00 ($56,000)

  • Chief Financial Officer acquired 800 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Agarwal Vineet · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-11 Exercise or conversion : show line 1 in the form 10b5-1 +800 $11.68 $9,344 800 D
2024-11-11 Sale : show line 2 in the form 10b5-1 −800 $70.00 $56,000 0 D
Open-market sales · 800 sh · avg $70.00 · $56,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-11 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −800 30,807 D
Loading xslF345X05/ownership.xml…